Jack Ball

Mr. Ball joined KromaTiD’s board in 2021. He is President of Tyball Associates, a commercialization strategy consulting firm in the biotech tools space. He serves on the board of directors of Carterra, Cytek Biosciences, and NanoCellect. Mr. Ball was on the board at Swift Bioscience for 11 years until it sold to Integrated DNA Technology in March 2021. Most recently he was CEO, Solulink. Prior to that he was CCO at Accuri Cytometers which was sold to Becton Dickinson in March 2011, and before that he was CEO of Amnis Corporation. He also served in executive roles at Molecular Probes, Orchid Biosciences, and Amersham Pharmacia Biotech (where he rose to President for North America). Mr. Ball has a B.S. degree in Agriculture from University of Georgia.